Paroxetine Hydrochloride Patent Expiration

Paroxetine Hydrochloride is Used for treating various mental health disorders such as depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, and posttraumatic stress disorder. It was first introduced by Apotex Inc in its drug Paxil on Dec 29, 1992. Another drug containing Paroxetine Hydrochloride is Paxil Cr. 23 different companies have introduced drugs containing Paroxetine Hydrochloride.

Paroxetine Hydrochloride Patents

Given below is the list of patents protecting Paroxetine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Paxil	US6063927 (Pediatric)	Paroxetine derivatives	Oct 23, 2019 (Expired)	Apotex
Paxil	US6063927	Paroxetine derivatives	Apr 23, 2019 (Expired)	Apotex
Paxil	US6172233 (Pediatric)	Process for making paroxetine	Jul 15, 2018 (Expired)	Apotex
Paxil	US6172233	Process for making paroxetine	Jan 15, 2018 (Expired)	Apotex
Paxil	US6121291 (Pediatric)	Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder	Sep 17, 2017 (Expired)	Apotex
Paxil Cr	US6121291 (Pediatric)	Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder	Sep 17, 2017 (Expired)	Apotex
Paxil	US6121291	Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder	Mar 17, 2017 (Expired)	Apotex
Paxil Cr	US6121291	Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder	Mar 17, 2017 (Expired)	Apotex
Paxil Cr	US6548084 (Pediatric)	Controlled release compositions	Jan 19, 2017 (Expired)	Apotex
Paxil Cr	US7229640 (Pediatric)	Paroxetine controlled release compositions	Jan 19, 2017 (Expired)	Apotex
Paxil Cr	US6548084	Controlled release compositions	Jul 19, 2016 (Expired)	Apotex
Paxil Cr	US7229640	Paroxetine controlled release compositions	Jul 19, 2016 (Expired)	Apotex
Paxil	US5811436 (Pediatric)	Oral liquid compositions containing paroxetine resinate	Mar 22, 2016 (Expired)	Apotex
Paxil	US5872132 (Pediatric)	Form of paroxetine hydrochloride anhydrate	Nov 19, 2015 (Expired)	Apotex
Paxil	US5900423 (Pediatric)	Form of paroxetine hydrochloride anhydrate	Nov 19, 2015 (Expired)	Apotex
Paxil	US6080759 (Pediatric)	Paroxetine hydrochloride form A	Nov 19, 2015 (Expired)	Apotex
Paxil	US6133289 (Pediatric)	Paroxetine hydrochloride form A or C	Nov 19, 2015 (Expired)	Apotex
Paxil Cr	US5872132 (Pediatric)	Form of paroxetine hydrochloride anhydrate	Nov 19, 2015 (Expired)	Apotex
Paxil Cr	US5900423 (Pediatric)	Form of paroxetine hydrochloride anhydrate	Nov 19, 2015 (Expired)	Apotex
Paxil Cr	US6133289 (Pediatric)	Paroxetine hydrochloride form A or C	Nov 19, 2015 (Expired)	Apotex
Paxil	US5811436	Oral liquid compositions containing paroxetine resinate	Sep 22, 2015 (Expired)	Apotex
Paxil	US6113944 (Pediatric)	Paroxetine tablets and process to prepare them	Jun 14, 2015 (Expired)	Apotex
Paxil	US5872132	Form of paroxetine hydrochloride anhydrate	May 19, 2015 (Expired)	Apotex
Paxil	US5900423	Form of paroxetine hydrochloride anhydrate	May 19, 2015 (Expired)	Apotex
Paxil	US6080759	Paroxetine hydrochloride form A	May 19, 2015 (Expired)	Apotex
Paxil	US6133289	Paroxetine hydrochloride form A or C	May 19, 2015 (Expired)	Apotex
Paxil Cr	US5872132	Form of paroxetine hydrochloride anhydrate	May 19, 2015 (Expired)	Apotex
Paxil Cr	US5900423	Form of paroxetine hydrochloride anhydrate	May 19, 2015 (Expired)	Apotex
Paxil Cr	US6133289	Paroxetine hydrochloride form A or C	May 19, 2015 (Expired)	Apotex
Paxil	US6113944	Paroxetine tablets and process to prepare them	Dec 14, 2014 (Expired)	Apotex
Paxil Cr	US5422123 (Pediatric)	Tablets with controlled-rate release of active substances	Dec 06, 2012 (Expired)	Apotex

Paroxetine Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Paroxetine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Paroxetine Hydrochloride. The first generic version for Paroxetine Hydrochloride was by Apotex Inc and was approved on Jul 30, 2003. And the latest generic version is by Prinston Pharmaceutical Inc and was approved on Jan 4, 2024.

Given below is the list of companies who have filed for Paroxetine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.

1. APOTEX

Apotex Inc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Prescription	ORAL	AB	Jul 30, 2003
EQ 20MG BASE	tablet	Prescription	ORAL	AB	Jul 30, 2003
EQ 30MG BASE	tablet	Prescription	ORAL	AB	Jul 30, 2003
EQ 40MG BASE	tablet	Prescription	ORAL	AB	Jul 30, 2003

Manufacturing Plant Locations
^New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country

City

Firm Name

United States

Weston

Apotex Corp.

Canada

Toronto	Apotex Inc.
Brantford	Apotex Pharmachem Inc.
Etobicoke	Apotex, Inc.
Winnipeg	Apotex Fermentation Inc.
North York	Apotex Inc.
Richmond Hill	Apotex Inc.

India

Bangalore	Apotex Pharmachem India Pvt Ltd.
Bangalore	Apotex Research Private Limited - Bioequivalence Centre
Bengaluru	Apotex Research Private Limited

2. APOTEX INC

Apotex Inc has filed for 1 generic for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE/5ML	suspension	Discontinued	ORAL	N/A	Dec 5, 2006

Manufacturing Plant Locations
^New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country

City

Firm Name

Canada

Toronto	Apotex Inc.
North York	Apotex Inc.
Richmond Hill	Apotex Inc.

3. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 40MG BASE	tablet	Prescription	ORAL	AB	Jul 25, 2007
EQ 10MG BASE	tablet	Prescription	ORAL	AB	Jul 25, 2007
EQ 20MG BASE	tablet	Prescription	ORAL	AB	Jul 25, 2007
EQ 30MG BASE	tablet	Prescription	ORAL	AB	Jul 25, 2007

Manufacturing Plant Locations
^New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country

City

Firm Name

India

Polepally, Mahaboob Nagar	Aurobindo Pharma Limited
Medchal	Aurobindo Pharma Ltd
Sangareddy	Aurobindo Pharma Limited
Bachupally	Aurobindo Pharma Limited

United States

East Windsor

Aurobindo Pharma USA Inc

4. AUROBINDO PHARMA USA

Aurobindo Pharma Usa Inc has filed for 3 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 12.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 29, 2007
EQ 25MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 29, 2007
EQ 37.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Apr 14, 2011

Manufacturing Plant Locations
^New

Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.

Country

City

Firm Name

United States

East Windsor

Aurobindo Pharma USA Inc

5. CADILA PHARMS LTD

Cadila Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cadila Pharms Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 12.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 27, 2021
EQ 25MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 27, 2021
EQ 37.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 27, 2021

6. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 30MG BASE	tablet	Prescription	ORAL	AB	Aug 15, 2005
EQ 40MG BASE	tablet	Prescription	ORAL	AB	Aug 15, 2005
EQ 10MG BASE	tablet	Prescription	ORAL	AB	Aug 15, 2005
EQ 20MG BASE	tablet	Prescription	ORAL	AB	Aug 15, 2005

7. CSPC OUYI

Cspc Ouyi Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cspc Ouyi.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 37.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Feb 16, 2021
EQ 12.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Feb 16, 2021
EQ 25MG BASE	tablet, extended release	Prescription	ORAL	AB	Feb 16, 2021

Manufacturing Plant Locations
^New

Cspc Ouyi's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Cspc Ouyi as present at those locations.

Country

City

Firm Name

China

Shijiazhuang

CSPC Ouyi Pharmaceutical Co., Ltd.

8. EPIC PHARMA LLC

Epic Pharma Llc has filed for 3 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Aug 11, 2021
EQ 12.5MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Aug 11, 2021
EQ 37.5MG BASE	tablet, extended release	Discontinued	ORAL	N/A	May 26, 2022

9. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Discontinued	ORAL	N/A	Nov 27, 2015
EQ 30MG BASE	tablet	Discontinued	ORAL	N/A	Nov 27, 2015
EQ 40MG BASE	tablet	Discontinued	ORAL	N/A	Nov 27, 2015
EQ 20MG BASE	tablet	Discontinued	ORAL	N/A	Nov 27, 2015

Manufacturing Plant Locations
^New

Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.

Country

City

Firm Name

India

Roorkee

Jubilant Generics Limited

10. LANNETT CO INC

Lannett Co Inc has filed for 3 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 10, 2016
EQ 37.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 10, 2016
EQ 12.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 10, 2016

11. LUPIN LTD

Lupin Ltd has filed for 3 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 25MG BASE	tablet, extended release	Prescription	ORAL	AB	Jan 20, 2017
EQ 12.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Jan 20, 2017
EQ 37.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Jan 20, 2017

Manufacturing Plant Locations
^New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country

City

Firm Name

India

Aurangabad

Lupin Ltd.

12. MYLAN

Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Prescription	ORAL	AB	Mar 13, 2008
EQ 20MG BASE	tablet	Prescription	ORAL	AB	Mar 13, 2008
EQ 30MG BASE	tablet	Prescription	ORAL	AB	Mar 13, 2008
EQ 40MG BASE	tablet	Prescription	ORAL	AB	Mar 13, 2008

Manufacturing Plant Locations
^New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country

City

Firm Name

United States

Rockford	Mylan Institutional, Inc.
Santa Barbara	Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos	Mylan Pharmaceuticals Inc.
Morgantown	MYLAN CONSUMER HEALTHCARE Inc.
Morgantown	Mylan Specialty, L.P.
Saint Albans	Mylan Technologies, Inc.
Greensboro	Mylan Pharmaceuticals Inc

India

Hyderabad	Mylan Laboratories Limited
Sarigam	Mylan Laboratories Limited
Bangalore	Mylan Laboratories Limited
Anekal Taluk, Bangalore	Mylan Laboratories Limited
Pithampur, District Dhar	Mylan Laboratories Limited
Sinnar	Mylan Laboratories Limited
Hosur	Mylan Laboratories Limited
Aurangabad	Mylan Laboratories Limited (FDF-2)

Canada

Etobicoke

Mylan Pharmaceuticals ULC

Ireland

Inverin

Mylan Teoranta

13. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Discontinued	ORAL	N/A	Mar 8, 2004
EQ 20MG BASE	tablet	Discontinued	ORAL	N/A	Mar 8, 2004
EQ 30MG BASE	tablet	Discontinued	ORAL	N/A	Mar 8, 2004
EQ 40MG BASE	tablet	Discontinued	ORAL	N/A	Mar 8, 2004

14. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 1 generic for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE/5ML (reference standard)	suspension	Prescription	ORAL	N/A	Sep 3, 2021

Strength

Dosage Form

Availability

Application Pathway

TE code

Launch Date

EQ 10MG BASE/5ML

suspension

Prescription

ORAL

N/A

Sep 3, 2021

Manufacturing Plant Locations
^New

Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.

Country

City

Firm Name

United States

East Windsor

Novitium Pharma LLC

15. OXFORD PHARMS

Oxford Pharmaceuticals Llc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Oxford Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Prescription	ORAL	AB	Jun 21, 2010
EQ 40MG BASE	tablet	Prescription	ORAL	AB	Jun 21, 2010
EQ 20MG BASE	tablet	Prescription	ORAL	AB	Jun 21, 2010
EQ 30MG BASE	tablet	Prescription	ORAL	AB	Jun 21, 2010

16. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 6 different strengths of generic version for Paroxetine Hydrochloride. Out of these eq 10mg base version comes by the name PAROXETINE, eq 20mg base version comes by the name PAROXETINE, eq 30mg base version comes by the name PAROXETINE, eq 40mg base version comes by the name PAROXETINE. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Prescription	ORAL	AB	Oct 31, 2014
EQ 20MG BASE	tablet	Prescription	ORAL	AB	Oct 31, 2014
EQ 30MG BASE	tablet	Prescription	ORAL	AB	Oct 31, 2014
EQ 40MG BASE	tablet	Prescription	ORAL	AB	Oct 31, 2014
EQ 12.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Jan 4, 2024
EQ 25MG BASE	tablet, extended release	Prescription	ORAL	AB	Jan 4, 2024

17. ROXANE

Roxane Laboratories Inc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Roxane.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 20MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 30MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 40MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007

18. SCIECURE PHARMA INC

Sciecure Pharma Inc has filed for 3 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sciecure Pharma Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 12.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 12, 2018
EQ 25MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 12, 2018
EQ 37.5MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 12, 2018

19. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 20MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 30MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 40MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007

20. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 40MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 10MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 20MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007
EQ 30MG BASE	tablet	Discontinued	ORAL	N/A	Jun 29, 2007

21. UPSHER SMITH LABS

Upsher Smith Laboratories Llc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 30MG BASE	tablet	Discontinued	ORAL	N/A	Mar 8, 2004
EQ 10MG BASE	tablet	Discontinued	ORAL	N/A	Mar 8, 2004
EQ 20MG BASE	tablet	Discontinued	ORAL	N/A	Mar 8, 2004
EQ 40MG BASE	tablet	Discontinued	ORAL	N/A	Mar 8, 2004

22. YILING

Yiling Pharmaceutical Ltd has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Yiling.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Prescription	ORAL	AB	Nov 2, 2021
EQ 30MG BASE	tablet	Prescription	ORAL	AB	Nov 2, 2021
EQ 40MG BASE	tablet	Prescription	ORAL	AB	Nov 2, 2021
EQ 20MG BASE	tablet	Prescription	ORAL	AB	Nov 2, 2021

Manufacturing Plant Locations
^New

Yiling's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yiling as present at those locations.

Country

City

Firm Name

China

Shijiazhuang

Yiling Pharmaceutical Ltd.

23. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Paroxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 10MG BASE	tablet	Prescription	ORAL	AB	Mar 7, 2007
EQ 40MG BASE	tablet	Prescription	ORAL	AB	Mar 7, 2007
EQ 30MG BASE	tablet	Prescription	ORAL	AB	Mar 7, 2007
EQ 20MG BASE	tablet	Prescription	ORAL	AB	Mar 7, 2007

Pharsight

Pharsight

Paroxetine Hydrochloride Patents

Paroxetine Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Paroxetine Hydrochloride Generic API Manufacturers

1. APOTEX

Manufacturing Plant Locations New

2. APOTEX INC

Manufacturing Plant Locations New

3. AUROBINDO PHARMA

Manufacturing Plant Locations New

4. AUROBINDO PHARMA USA

Manufacturing Plant Locations New

5. CADILA PHARMS LTD

6. CHARTWELL RX

7. CSPC OUYI

Manufacturing Plant Locations New

8. EPIC PHARMA LLC

9. JUBILANT GENERICS

Manufacturing Plant Locations New

10. LANNETT CO INC

11. LUPIN LTD

Manufacturing Plant Locations New

12. MYLAN

Manufacturing Plant Locations New

13. NORVIUM BIOSCIENCE

14. NOVITIUM PHARMA

Manufacturing Plant Locations New

15. OXFORD PHARMS

16. PRINSTON INC

17. ROXANE

18. SCIECURE PHARMA INC

19. SUN PHARM INDS INC

20. TEVA PHARMS

21. UPSHER SMITH LABS

22. YILING

Manufacturing Plant Locations New

23. ZYDUS PHARMS USA

Related content

Have Questions?

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New